Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hannah

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Rheumatology Advances in Practice|December 19, 2022
Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statisticsJennifer R Hannah, Patrick A Gordon, James Galloway, et al.
The Journal of Infection|March 22, 2021
IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regressionEmmanuel Tharmarajah, April Buazon, Vishit Patel, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2006
Low molecular weight indole fragments as IMPDH inhibitorsRebekah E Beevers, George M Buckley, Natasha Davies, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2006
Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationshipsRebekah E Beevers, George M Buckley, Natasha Davies, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationshipsGeorge M Buckley, Natasha Davies, Hazel J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthmaG Buckley, N Cooper, H J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitorsHelen L Birch, George M Buckley, Natasha Davies, et al.
Rheumatology (Oxford, England)|December 1, 2023
Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung diseaseJennifer R Hannah, Alexandra Lawrence, Jennifer Martinovic, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and profile of SCH351591, a novel PDE4 inhibitorMotasim Billah, Nicola Cooper, Francis Cuss, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Rheumatology Advances in Practice|December 19, 2022
Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statisticsJennifer R Hannah, Patrick A Gordon, James Galloway, et al.
The Journal of Infection|March 22, 2021
IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regressionEmmanuel Tharmarajah, April Buazon, Vishit Patel, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2006
Low molecular weight indole fragments as IMPDH inhibitorsRebekah E Beevers, George M Buckley, Natasha Davies, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2006
Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationshipsRebekah E Beevers, George M Buckley, Natasha Davies, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationshipsGeorge M Buckley, Natasha Davies, Hazel J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthmaG Buckley, N Cooper, H J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitorsHelen L Birch, George M Buckley, Natasha Davies, et al.
Rheumatology (Oxford, England)|December 1, 2023
Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung diseaseJennifer R Hannah, Alexandra Lawrence, Jennifer Martinovic, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and profile of SCH351591, a novel PDE4 inhibitorMotasim Billah, Nicola Cooper, Francis Cuss, et al.
Pageof 5